Atlas Trials

Phase 2 Study of Gemzar, Taxol & Avastin Combination as 1st Line Treatment for Metastatic Breast Cancer

Clinical trial NCT00403130 · COMPLETED

Trial details

NCT number
NCT00403130
Sponsor
George Albert Fisher
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Breast CancerMetastatic Breast Cancer
Start date
2006-02-01
Primary completion
2010-09-01
Enrollment
31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.